Not Rated
|
Fund Size
(0.09% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 28-Oct-25 | 10075.20 | 0.75% | - | -0.24% | 26/227 |
| 1 Month | 03-Oct-25 | 10415.10 | 4.15% | - | 2.42% | 22/227 |
| 3 Month | 04-Aug-25 | 10114.00 | 1.14% | - | 4.18% | 197/223 |
| 6 Month | 02-May-25 | 10744.50 | 7.45% | - | 10.79% | 161/213 |
| YTD | 01-Jan-25 | 9717.40 | -2.83% | - | 5.36% | 174/201 |
| 1 Year | 04-Nov-24 | 10230.50 | 2.31% | 2.31% | 5.89% | 133/187 |
| Since Inception | 12-Dec-23 | 14201.00 | 42.01% | 20.29% | 14.33% | 45/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 04-Nov-24 | 12000 | 12544.72 | 4.54 % | 8.48 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 605.8 | 13.05% | 0.07% | 17.91% (Mar 2025) | 12.98% (Aug 2025) | 3.80 L | 0.00 |
| Max Healthcare Institute Ltd. | Hospital | 340 | 7.33% | -0.21% | 8.58% (Jun 2025) | 3.91% (Nov 2024) | 3.05 L | 0.00 |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 275.3 | 5.93% | -0.02% | 5.95% (Aug 2025) | 3.34% (Oct 2024) | 1.61 L | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 255.6 | 5.51% | -0.28% | 7.08% (Oct 2024) | 4.81% (Jul 2025) | 1.70 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 227.6 | 4.90% | -0.35% | 6.09% (May 2025) | 4.83% (Jan 2025) | 40.00 k | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 196.3 | 4.23% | -0.09% | 4.32% (Aug 2025) | 3.17% (May 2025) | 26.50 k | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 194 | 4.18% | 0.28% | 4.18% (Sep 2025) | 1.85% (Jan 2025) | 2.00 L | 0.00 |
| Lupin Ltd. | Pharmaceuticals | 181.6 | 3.91% | 0.05% | 3.91% (Sep 2025) | 2.86% (Jul 2025) | 95.00 k | 0.00 |
| Jubilant Life Sciences Ltd. | Pharmaceuticals | 151.1 | 3.26% | 0.19% | 4.18% (Oct 2024) | 3.04% (Apr 2025) | 1.40 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 140 | 3.02% | 0.69% | 3.02% (Sep 2025) | 2.01% (Oct 2024) | 2.00 L | 50.00 k |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 2.56% |
| Net Receivables | Net Receivables | -0.24% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 406.67 | 1.34 | 26.29 | 63.29 | 46.69 | 41.91 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 266.19 | 0.53 | 7.20 | 22.20 | 32.42 | 19.61 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 279.13 | 3.89 | 14.04 | 26.62 | 24.04 | 17.95 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 289.73 | 1.05 | 8.61 | 18.40 | 22.70 | 20.55 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1651.55 | 1.08 | 11.03 | 29.10 | 22.29 | 0.00 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7024.28 | 0.27 | 6.46 | 18.11 | 20.13 | 0.00 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1419.62 | 4.00 | 6.90 | 10.70 | 19.63 | 0.00 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 655.17 | 3.03 | 4.42 | 20.17 | 19.07 | 0.00 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 311.03 | 5.15 | 7.04 | 9.15 | 18.85 | 15.83 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 8693.07 | 3.34 | 6.04 | 10.94 | 17.69 | 20.70 |
Out of 89 mutual fund schemes offered by this AMC, 8 is/are ranked 4 * , 9 is/are ranked 3 * , 7 is/are ranked 2 * , 2 is/are ranked 1 * , and 63 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Kotak Arbitrage Fund - Direct Plan - Growth | 3 | 71517.53 | 0.63 | 1.51 | 3.15 | 7.18 | 7.92 |
| Kotak Midcap Fund - Direct Plan - Growth | 4 | 58299.59 | 0.93 | 2.46 | 15.55 | 8.03 | 22.96 |
| Kotak Flexi Cap Fund - Direct Plan - Growth | 3 | 54083.13 | 1.99 | 3.00 | 8.74 | 10.13 | 17.26 |
| Kotak Money Market Fund - Direct Plan - Growth | 3 | 32820.86 | 0.50 | 1.46 | 3.42 | 7.69 | 7.65 |
| Kotak Liquid Fund - Direct Plan - Growth | 2 | 29473.72 | 0.48 | 1.45 | 3.05 | 6.78 | 7.07 |
| Kotak Large & Midcap Fund - Direct Plan - Growth | 3 | 28380.64 | 2.22 | 4.12 | 11.01 | 7.20 | 19.95 |
| Kotak Multicap Fund - Direct Plan - Growth | 4 | 20284.98 | 2.54 | 7.58 | 14.21 | 8.47 | 24.61 |
| Kotak Bond Short Term Plan - Direct Plan - Growth | 3 | 18155.54 | 0.63 | 1.30 | 3.29 | 8.48 | 8.19 |
| Kotak Corporate Bond Fund - Direct Plan - Growth | 3 | 17545.56 | 0.66 | 1.34 | 3.38 | 8.64 | 8.19 |
| Kotak Small Cap Fund - Direct Plan - Growth | 2 | 17480.17 | 1.73 | 1.04 | 11.44 | -4.23 | 17.91 |